Review



anti phosphorylated chk1  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc anti phosphorylated chk1
    Fig. 7. PCM1 promotes <t>CHK1</t> activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Anti Phosphorylated Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phosphorylated chk1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 50 article reviews
    anti phosphorylated chk1 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Pericentriolar material 1 aggregation maintains cell survival upon prolonged replication stress."

    Article Title: Pericentriolar material 1 aggregation maintains cell survival upon prolonged replication stress.

    Journal: Archives of biochemistry and biophysics

    doi: 10.1016/j.abb.2025.110383

    Fig. 7. PCM1 promotes CHK1 activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Figure Legend Snippet: Fig. 7. PCM1 promotes CHK1 activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Techniques Used: Activation Assay, Control, Western Blot, Inhibition

    Fig. 8. Autophagy maintains U2-OS cell viability upon prolonged replication stress. (A–B) Autophagy was induced by HU treatment in U2-OS cells. (A) LC3 puncta were examined by immunofluorescence staining with antibodies against LC3. DNA was stained with DAPI. Scale bar: 10 μm. (B) Quantitative results of (A). (C, upper panel) Extracts of HU-treated cells were analyzed by western blotting with antibodies against LC3 and actin. (C, lower panel) Quantitative results of upper panel. (D) Depletion of PCM1 alleviated HU-induced autophagy. Extracts of wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU were analyzed by western blotting with antibodies against LC3 and actin. (E) Quantitative results of (D). (F) Inhibition of autophagy reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers in wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU. (G) Graphic abstract of this study. Prolonged replication stress promotes centrosome amplification independent of PCM1 aggregation. However, PCM1 promotes DNA damage signaling the ATM-CHK1 axis and autophagy to sustain cell survival. n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Figure Legend Snippet: Fig. 8. Autophagy maintains U2-OS cell viability upon prolonged replication stress. (A–B) Autophagy was induced by HU treatment in U2-OS cells. (A) LC3 puncta were examined by immunofluorescence staining with antibodies against LC3. DNA was stained with DAPI. Scale bar: 10 μm. (B) Quantitative results of (A). (C, upper panel) Extracts of HU-treated cells were analyzed by western blotting with antibodies against LC3 and actin. (C, lower panel) Quantitative results of upper panel. (D) Depletion of PCM1 alleviated HU-induced autophagy. Extracts of wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU were analyzed by western blotting with antibodies against LC3 and actin. (E) Quantitative results of (D). (F) Inhibition of autophagy reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers in wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU. (G) Graphic abstract of this study. Prolonged replication stress promotes centrosome amplification independent of PCM1 aggregation. However, PCM1 promotes DNA damage signaling the ATM-CHK1 axis and autophagy to sustain cell survival. n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Techniques Used: Immunofluorescence, Staining, Western Blot, Inhibition, Amplification



    Similar Products

    94
    Cell Signaling Technology Inc anti phosphorylated chk1
    Fig. 7. PCM1 promotes <t>CHK1</t> activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Anti Phosphorylated Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phosphorylated chk1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti phosphorylated chk1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc phospho chk1
    Fig. 7. PCM1 promotes <t>CHK1</t> activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Phospho Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho chk1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phospho chk1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc 2347s cell signaling
    Fig. 7. PCM1 promotes <t>CHK1</t> activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    2347s Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2347s cell signaling/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    2347s cell signaling - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti phospho chk1
    Fig. 7. PCM1 promotes <t>CHK1</t> activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.
    Anti Phospho Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho chk1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti phospho chk1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc chk1
    β-arrestin1 mediates radiation-induced signaling pathway. A. Phosphorylation of ATR and <t>Chk1</t> were parallel to β-arrestin1 status, especially at 0 and 10 hs after radiation. B,C,D. radiation could activated ERK and NF-kB pathways within 60 minutes.
    Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chk1/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    chk1 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc phosphorylated chk1
    β-arrestin1 mediates radiation-induced signaling pathway. A. Phosphorylation of ATR and <t>Chk1</t> were parallel to β-arrestin1 status, especially at 0 and 10 hs after radiation. B,C,D. radiation could activated ERK and NF-kB pathways within 60 minutes.
    Phosphorylated Chk1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated chk1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phosphorylated chk1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc phospho chk1 antibody
    β-arrestin1 mediates radiation-induced signaling pathway. A. Phosphorylation of ATR and <t>Chk1</t> were parallel to β-arrestin1 status, especially at 0 and 10 hs after radiation. B,C,D. radiation could activated ERK and NF-kB pathways within 60 minutes.
    Phospho Chk1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho chk1 antibody/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phospho chk1 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 7. PCM1 promotes CHK1 activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Journal: Archives of biochemistry and biophysics

    Article Title: Pericentriolar material 1 aggregation maintains cell survival upon prolonged replication stress.

    doi: 10.1016/j.abb.2025.110383

    Figure Lengend Snippet: Fig. 7. PCM1 promotes CHK1 activation to maintain cell survival upon prolonged replication stress. (A) Depletion of PCM1 did not affect CHK2 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK2, CHK2, and tubulin (loading control). (B) Inhibition of CHK2 did not affect U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK2 inhibitor (CHK2i). (C) Depletion of PCM1 reduced CHK1 activation upon HU treatment. Extracts of control or PCM1-depleted cells were analyzed by western blotting with antibodies against phosphorylated CHK1, CHK1, and tubulin (loading control). (B) Inhibition of CHK1 reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers of HU-treated U2-OS cells in the presence of CHK1 inhibitor (CHK1i). n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Article Snippet: The following antibodies were used for immunofluorescence and Western blot assays: anti-γ-tubulin (Sigma), anti-PCM1, anti-phosphorylated ATR, anti-ATR, anti-CHK1, anti-CHK2, anti-phosphorylated CHK1, anti-phosphorylated CHK2, anti-LC3 A/B (Cell Signaling), antip150glued, anti-GM130 (BD Biosciences), anti-Ku70, anti-α-tubulin, antiATM, anti-β-actin (GeneTex), anti-γ-H2AX, anti-p-ATM (Abcam), antiphosphorylated DNA-PKcs, anti-DNA-PKcs (Santa Cruz Biotech).

    Techniques: Activation Assay, Control, Western Blot, Inhibition

    Fig. 8. Autophagy maintains U2-OS cell viability upon prolonged replication stress. (A–B) Autophagy was induced by HU treatment in U2-OS cells. (A) LC3 puncta were examined by immunofluorescence staining with antibodies against LC3. DNA was stained with DAPI. Scale bar: 10 μm. (B) Quantitative results of (A). (C, upper panel) Extracts of HU-treated cells were analyzed by western blotting with antibodies against LC3 and actin. (C, lower panel) Quantitative results of upper panel. (D) Depletion of PCM1 alleviated HU-induced autophagy. Extracts of wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU were analyzed by western blotting with antibodies against LC3 and actin. (E) Quantitative results of (D). (F) Inhibition of autophagy reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers in wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU. (G) Graphic abstract of this study. Prolonged replication stress promotes centrosome amplification independent of PCM1 aggregation. However, PCM1 promotes DNA damage signaling the ATM-CHK1 axis and autophagy to sustain cell survival. n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Journal: Archives of biochemistry and biophysics

    Article Title: Pericentriolar material 1 aggregation maintains cell survival upon prolonged replication stress.

    doi: 10.1016/j.abb.2025.110383

    Figure Lengend Snippet: Fig. 8. Autophagy maintains U2-OS cell viability upon prolonged replication stress. (A–B) Autophagy was induced by HU treatment in U2-OS cells. (A) LC3 puncta were examined by immunofluorescence staining with antibodies against LC3. DNA was stained with DAPI. Scale bar: 10 μm. (B) Quantitative results of (A). (C, upper panel) Extracts of HU-treated cells were analyzed by western blotting with antibodies against LC3 and actin. (C, lower panel) Quantitative results of upper panel. (D) Depletion of PCM1 alleviated HU-induced autophagy. Extracts of wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU were analyzed by western blotting with antibodies against LC3 and actin. (E) Quantitative results of (D). (F) Inhibition of autophagy reduced U2-OS cell viability upon HU treatment. Quantitative results of relative cell numbers in wild-type or PCM1-depleted (siPCM1) cells in the presence or absence of HU. (G) Graphic abstract of this study. Prolonged replication stress promotes centrosome amplification independent of PCM1 aggregation. However, PCM1 promotes DNA damage signaling the ATM-CHK1 axis and autophagy to sustain cell survival. n.s.: no significance, ***: P < 0.001. Each experiment was repeated at least three times.

    Article Snippet: The following antibodies were used for immunofluorescence and Western blot assays: anti-γ-tubulin (Sigma), anti-PCM1, anti-phosphorylated ATR, anti-ATR, anti-CHK1, anti-CHK2, anti-phosphorylated CHK1, anti-phosphorylated CHK2, anti-LC3 A/B (Cell Signaling), antip150glued, anti-GM130 (BD Biosciences), anti-Ku70, anti-α-tubulin, antiATM, anti-β-actin (GeneTex), anti-γ-H2AX, anti-p-ATM (Abcam), antiphosphorylated DNA-PKcs, anti-DNA-PKcs (Santa Cruz Biotech).

    Techniques: Immunofluorescence, Staining, Western Blot, Inhibition, Amplification

    β-arrestin1 mediates radiation-induced signaling pathway. A. Phosphorylation of ATR and Chk1 were parallel to β-arrestin1 status, especially at 0 and 10 hs after radiation. B,C,D. radiation could activated ERK and NF-kB pathways within 60 minutes.

    Journal: Journal of Cancer

    Article Title: Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer

    doi: 10.7150/jca.30012

    Figure Lengend Snippet: β-arrestin1 mediates radiation-induced signaling pathway. A. Phosphorylation of ATR and Chk1 were parallel to β-arrestin1 status, especially at 0 and 10 hs after radiation. B,C,D. radiation could activated ERK and NF-kB pathways within 60 minutes.

    Article Snippet: Anti-β-arrestin1, -ATR, -Chk1, -H2AX, -ERK, -PARP, and -NF-kB; anti-phosphorylated ATR (Ser428), Chk1 (Ser345), BRCA1 (Ser1524), ERK (Thr202/Tyr204), γ-H2AX (Ser139), and -NF-kB p65 (Ser536) antibodies were all purchased from Cell Signaling Technology, USA.

    Techniques: